Get a Complete Understanding of Immune Response with NovorIg™.

With NovorIg™, you can quantify the immune response by accurately profiling the vast antibody-protein repertoire and its different isotypes, and subtypes in serum over time.

Extracting Beneath the Surface

Traditional approaches that profile the immune response typically rely on the isolation and nucleotide sequencing of circulating B-cells. Although these approaches are still important, they may not completely reflect the full antibody-protein repertoire and may provide a superficial account of the immune response. With NovorIg™ you can now take your insights to a deeper level.

Rapidly Mine the Immune Response.

NovorIg™ rapidly mines the immune response with greater depth. By exploiting our proteomics and bioinformatics, NovorIg™ decodes the exact immune response at specific time points by mining the antibody repertoire in great depth with a combined analysis of the B-cells and antibody proteins.

Reproducibility impacts.

$0
USD $1.7 billion wasted each year on commercial antibodies that don’t work as expected. $25 billion wasted on non-reproducible pre-clinical research.
0%
As many as 50% of reagent antibodies are shown to not recognize their targets. 32% of Hybridomas produce unintended antibodies.
0%
Only 6 out of 53 landmark pre-clinical studies could be reproduced in one study. That’s a staggering 88% failure rate.

Who uses MATCHmAb.

Researchers, Antibody Users

Researchers use tool antibodies every day, across many applications. Sequence confirmation is the first step in troubleshooting, or daily quality checks to prevent issues.

Antibody Venders, Producers

Easily verify each new lot. Offer premium Verified by MATCHmAb products, or an add-on service.

Antibody Engineering

Cell line instability could introduce mutations to humanized antibodies. Verify the CDRs have not changed or confirm the full expressed sequence matches the engineered one.

CRO, Custom Developers

Checkpoints to increase confidence. Avoid troubleshooting re-runs with clients.

How NovorIg Works.

MATCHmAb
Workflow LC-MS/MS, single or dual digest
Bioinformatics Real-time analysis, purpose built algorithms
Speed Fast: 1-4 days
Throughput High: > 100 per week
Coverage Higher, and amino acid level
 Traditional Peptide Mapping
Workflow LC-MS only, single enzyme only
Bioinformatics Post-processing, off the shelf tools
Speed Slow: weeks
Throughput Low
Coverage Lower, and only peptide level

Enhanced Examination.

NovorIg™ offers researchers the ability to enhance their examination of the humoral immune response in different conditions including immunity cohort studies for disease diagnosis and prognosis by exploiting the biomarker nature of the antibody repertoire.

Talk to Our Scientists.

We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

We Have Sequenced 4000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics

Talk to our scientists. We have sequenced over 4000 antibodies and we are eager to help you.